These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12231517)

  • 1. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
    Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.
    Conry RM; White SA; Fultz PN; Khazaeli MB; Strong TV; Allen KO; Barlow DL; Moore SE; Coan PN; Davis I; Curiel DT; LoBuglio AF
    Clin Cancer Res; 1998 Nov; 4(11):2903-12. PubMed ID: 9829759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.
    Conry RM; Khazaeli MB; Saleh MN; Allen KO; Barlow DL; Moore SE; Craig D; Arani RB; Schlom J; LoBuglio AF
    Clin Cancer Res; 1999 Sep; 5(9):2330-7. PubMed ID: 10499601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A carcinoembryonic antigen polynucleotide vaccine for human clinical use.
    Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT
    Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.
    Conry RM; Allen KO; Lee S; Moore SE; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2000 Jan; 6(1):34-41. PubMed ID: 10656429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas.
    von Mehren M; Arlen P; Tsang KY; Rogatko A; Meropol N; Cooper HS; Davey M; McLaughlin S; Schlom J; Weiner LM
    Clin Cancer Res; 2000 Jun; 6(6):2219-28. PubMed ID: 10873071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
    Harrop R; Connolly N; Redchenko I; Valle J; Saunders M; Ryan MG; Myers KA; Drury N; Kingsman SM; Hawkins RE; Carroll MW
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3416-24. PubMed ID: 16740766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma.
    Weber J; Boswell W; Smith J; Hersh E; Snively J; Diaz M; Miles S; Liu X; Obrocea M; Qiu Z; Bot A
    J Immunother; 2008; 31(2):215-23. PubMed ID: 18481391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM; Schlom J; Hodge JW
    Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.
    Morse MA; Clay TM; Hobeika AC; Osada T; Khan S; Chui S; Niedzwiecki D; Panicali D; Schlom J; Lyerly HK
    Clin Cancer Res; 2005 Apr; 11(8):3017-24. PubMed ID: 15837756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
    Huang Y; Fayad R; Smock A; Ullrich AM; Qiao L
    Cancer Res; 2005 Aug; 65(15):6990-9. PubMed ID: 16061685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen.
    Kim JJ; Yang JS; Nottingham LK; Tang W; Dang K; Manson KH; Wyand MS; Wilson DM; Weiner DB
    Oncogene; 2001 Jul; 20(33):4497-506. PubMed ID: 11494145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
    Samonigg H; Wilders-Truschnig M; Kuss I; Plot R; Stöger H; Schmid M; Bauernhofer T; Tiran A; Pieber T; Havelec L; Loibner H
    J Immunother; 1999 Nov; 22(6):481-8. PubMed ID: 10570746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
    Moulton HM; Yoshihara PH; Mason DH; Iversen PL; Triozzi PL
    Clin Cancer Res; 2002 Jul; 8(7):2044-51. PubMed ID: 12114402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology evaluation: CEA-TRICOM, Therion Biologics Corp.
    Morse MA
    Curr Opin Mol Ther; 2001 Aug; 3(4):407-12. PubMed ID: 11525565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients.
    Staff C; Mozaffari F; Haller BK; Wahren B; Liljefors M
    Vaccine; 2011 Sep; 29(39):6817-22. PubMed ID: 21195077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.